SMHGF
Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its princi… Read more
SMHGF (SMHGF) - Total Liabilities
Latest total liabilities as of June 2025: $5.37 Billion USD
Based on the latest financial reports, SMHGF (SMHGF) has total liabilities worth $5.37 Billion USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SMHGF - Total Liabilities Trend (2020–2024)
This chart illustrates how SMHGF's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SMHGF Competitors by Total Liabilities
The table below lists competitors of SMHGF ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jinxi Axle Co Ltd
SHG:600495
|
China | CN¥760.99 Million |
|
SZZT Electronics Co Ltd
SHE:002197
|
China | CN¥3.54 Billion |
|
COHTF
PINK:COHTF
|
USA | $247.03 Million |
|
Hefei Chipmore Technology Co. Ltd. A
SHG:688352
|
China | CN¥856.38 Million |
|
Mersen SA
PA:MRN
|
France | €1.01 Billion |
|
Metallus, Inc
NYSE:MTUS
|
USA | $452.70 Million |
|
Kelington Group Bhd
KLSE:0151
|
Malaysia | RM645.95 Million |
|
Aucma Co Ltd
SHG:600336
|
China | CN¥4.92 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down SMHGF's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SMHGF's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SMHGF (2020–2024)
The table below shows the annual total liabilities of SMHGF from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $4.44 Billion | +22.33% |
| 2023-12-31 | $3.63 Billion | -0.28% |
| 2022-12-31 | $3.64 Billion | -1.55% |
| 2021-12-31 | $3.70 Billion | -34.05% |
| 2020-12-31 | $5.61 Billion | -- |